KFG Wealth Management’s Idexx Laboratories IDXX Stock Holding History

KFG Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$518K	Sell	921 -7	-0.8%	-$4.49K	0.07%	129
2025 Q4	$628K	Sell	928 -94	-9%	-$64K	0.08%	107
2025 Q3	$653K	Sell	1,022 -400	-28%	-$243K	0.09%	105
2025 Q2	$763K	Buy	1,422 +31	+2%	+$14.8K	0.12%	94
2025 Q1	$584K	Buy	1,391 +299	+27%	+$130K	0.11%	109
2024 Q4	$451K	Buy	1,092 +99	+10%	+$43.4K	0.08%	117
2024 Q3	$502K	Buy	993 +49	+5%	+$23.8K	0.11%	113
2024 Q2	$460K	Buy	944 +48	+5%	+$24.1K	0.18%	100
2024 Q1	$484K	Sell	896 -73	-8%	-$39.9K	0.2%	93
2023 Q4	$538K	Buy	+969	New	+$455K	0.25%	71

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KFG Wealth Management's IDXX Position: Q1 2026 in Review

KFG Wealth Management reduced its Idexx Laboratories (IDXX) stake by 0.75% in Q1 2026, selling an estimated $4.49K and leaving 921 shares worth $518K. The position accounts for 0.07% of the portfolio, ranked #129.

KFG Wealth Management first reported a position in IDXX in Q4 2023 and has held it in 10 quarters since. The position peaked at $763K in Q2 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

KFG Wealth Management held 921 shares of Idexx Laboratories worth $518K as of Q1 2026.
KFG Wealth Management sold 7 Idexx Laboratories shares in Q1 2026, an estimated $4.49K.
Idexx Laboratories made up 0.07% of KFG Wealth Management's portfolio in Q1 2026, its #129 holding.
KFG Wealth Management first reported a position in Idexx Laboratories in Q4 2023 and has held it in 10 quarters since.
KFG Wealth Management's Idexx Laboratories position peaked at $763K in Q2 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on KFG Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.